Titan Pharmaceuticals (TTNP) Competitors $4.03 +0.03 (+0.75%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends TTNP vs. BCDA, BBI, ONVO, CLDI, INAB, AWH, NRXP, AVTX, PMCB, and SNSEShould you be buying Titan Pharmaceuticals stock or one of its competitors? The main competitors of Titan Pharmaceuticals include BioCardia (BCDA), Brickell Biotech (BBI), Organovo (ONVO), Calidi Biotherapeutics (CLDI), IN8bio (INAB), Aspira Women's Health (AWH), NRx Pharmaceuticals (NRXP), Avalo Therapeutics (AVTX), PharmaCyte Biotech (PMCB), and Sensei Biotherapeutics (SNSE). These companies are all part of the "medical" sector. Titan Pharmaceuticals vs. BioCardia Brickell Biotech Organovo Calidi Biotherapeutics IN8bio Aspira Women's Health NRx Pharmaceuticals Avalo Therapeutics PharmaCyte Biotech Sensei Biotherapeutics Titan Pharmaceuticals (NASDAQ:TTNP) and BioCardia (NASDAQ:BCDA) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and community ranking. Which has higher valuation & earnings, TTNP or BCDA? Titan Pharmaceuticals has higher earnings, but lower revenue than BioCardia. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTitan Pharmaceuticals$180K20.46-$5.57MN/AN/ABioCardia$428K11.81-$11.57M-$5.38-0.44 Do insiders and institutionals hold more shares of TTNP or BCDA? 31.5% of Titan Pharmaceuticals shares are owned by institutional investors. Comparatively, 20.6% of BioCardia shares are owned by institutional investors. 24.9% of Titan Pharmaceuticals shares are owned by insiders. Comparatively, 20.0% of BioCardia shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community prefer TTNP or BCDA? Titan Pharmaceuticals received 321 more outperform votes than BioCardia when rated by MarketBeat users. However, 56.00% of users gave BioCardia an outperform vote while only 55.01% of users gave Titan Pharmaceuticals an outperform vote. CompanyUnderperformOutperformTitan PharmaceuticalsOutperform Votes33555.01% Underperform Votes27444.99% BioCardiaOutperform Votes1456.00% Underperform Votes1144.00% Is TTNP or BCDA more profitable? Titan Pharmaceuticals has a net margin of 0.00% compared to BioCardia's net margin of -1,999.77%. BioCardia's return on equity of 0.00% beat Titan Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Titan PharmaceuticalsN/A -87.90% -75.11% BioCardia -1,999.77%N/A -278.27% Do analysts prefer TTNP or BCDA? BioCardia has a consensus target price of $25.00, indicating a potential upside of 950.42%. Given BioCardia's higher probable upside, analysts plainly believe BioCardia is more favorable than Titan Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ABioCardia 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, TTNP or BCDA? Titan Pharmaceuticals has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, BioCardia has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Does the media refer more to TTNP or BCDA? In the previous week, BioCardia had 2 more articles in the media than Titan Pharmaceuticals. MarketBeat recorded 3 mentions for BioCardia and 1 mentions for Titan Pharmaceuticals. Titan Pharmaceuticals' average media sentiment score of 0.00 equaled BioCardia'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Titan Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BioCardia 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryTitan Pharmaceuticals and BioCardia tied by winning 7 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Titan Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TTNP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTNP vs. The Competition Export to ExcelMetricTitan PharmaceuticalsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.68M$3.11B$5.02B$8.40BDividend YieldN/A1.76%7.52%4.16%P/E RatioN/A15.53128.6616.67Price / Sales20.46311.891,718.2576.46Price / CashN/A144.3536.9133.53Price / Book0.463.974.595.18Net Income-$5.57M-$42.08M$114.09M$223.67M7 Day Performance5.50%-0.60%110.28%2.59%1 Month Performance-23.96%8.78%124.25%8.66%1 Year Performance-52.33%28.73%154.82%28.23% Titan Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTNPTitan Pharmaceuticals0.9787 of 5 stars$4.03+0.8%N/A-52.3%$3.68M$180,000.000.0010Upcoming EarningsNews CoverageGap DownBCDABioCardia2.5683 of 5 stars$2.38-0.4%$25.00+950.4%-60.3%$5.06M$428,000.00-0.4416Gap UpBBIBrickell BiotechN/AN/AN/AN/A$6.75M$4.64M-0.1716ONVOOrganovo0.187 of 5 stars$0.44-4.3%N/A-73.9%$6.81M$110,000.00-0.3220Analyst ForecastNews CoverageCLDICalidi Biotherapeutics2.2656 of 5 stars$1.32-2.2%$16.67+1,162.6%N/A$14.67M$50,000.000.0041High Trading VolumeINABIN8bio3.3993 of 5 stars$0.30+7.0%$10.00+3,181.9%-70.7%$14.26MN/A-0.3720Positive NewsHigh Trading VolumeAWHAspira Women's Health1.1711 of 5 stars$0.89-1.1%$4.40+396.6%-81.2%$14.23M$8.92M-0.61110Upcoming EarningsGap DownNRXPNRx Pharmaceuticals1.5519 of 5 stars$1.32-4.3%$31.50+2,286.4%-96.0%$14.19MN/A-0.492Upcoming EarningsAVTXAvalo Therapeutics1.9632 of 5 stars$13.54+4.4%N/A-45.4%$14M$807,000.000.0040Positive NewsPMCBPharmaCyte Biotech0.6761 of 5 stars$1.74-4.9%N/A-22.0%$13.36MN/A2.642Gap DownSNSESensei Biotherapeutics4.3373 of 5 stars$0.52+6.1%$4.33+734.9%-24.8%$13.05MN/A-0.4440News CoverageGap Up Related Companies and Tools Related Companies BioCardia Alternatives Brickell Biotech Alternatives Organovo Alternatives Calidi Biotherapeutics Alternatives IN8bio Alternatives Aspira Women's Health Alternatives NRx Pharmaceuticals Alternatives Avalo Therapeutics Alternatives PharmaCyte Biotech Alternatives Sensei Biotherapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TTNP) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TTNP Stock Alerts